Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy

By Li Shouwei   Zhang Wei   Chen Baoshi   Jiang Tao   Wang Zhongcheng  

Neurological Research, Vol. 32, Iss. 7, 2010-09 ,pp. : 690-694

Maney Publishing

Access to resources Recommend Favorite

MGMT repletion after treatment of glioblastoma cells with temozolomide and O6-benzylguanine implicates NFκB and mutant p53

By Vlachostergios Panagiotis J   Hatzidaki Eleana   Papandreou Christos N  

Neurological Research, Vol. 35, Iss. 8, 2013-10 ,pp. : 879-882

Maney Publishing

Access to resources Recommend Favorite

Immunohistochemical profiles of IDH1, MGMT and P53: Practical significance for prognostication of patients with diffuse gliomas

By  

Neuropathology (Electronic), Vol. 35, Iss. 4, 2015-08 ,pp. : 324-335

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma

By Giannini Caterina   Hebrink Deanne   Scheithauer Bernd   Dei Tos Angelo   James Charles  

Neurogenetics, Vol. 3, Iss. 3, 2001-07 ,pp. : 159-162

Springer Publishing Company

Access to resources Recommend Favorite

Expression Profiling of p53-Target Genes in Copper-Mediated Neuronal Apoptosis

By VanLandingham Jacob W.   Tassabehji Nadine M.   Somers Rikki C.   Levenson Cathy W.  

NeuroMolecular Medicine, Vol. 7, Iss. 4, 2005-11 ,pp. : 311-324

Humana Press, Inc

Access to resources Recommend Favorite